epTools Downloads & RevenueepTools · App Store
epTools is #94 in Medical Paid in Russia and charting in 6 of 30 countries we track.
Updated 11 Nov 2026 · rankings refresh through the day
Full timeline · 12 events
- 📈epTools entered the top 100Top Paid · Medical · BR
- 📈epTools entered the top 100Top Paid · Medical · IT
- 📈epTools entered the top 100Top Paid · Medical · DE
- 📈epTools entered the top 100Top Grossing · Medical · GB
- 📈epTools entered the top 100Top Paid · Medical · CA
- 📈epTools charting in a new countryCanada
- 📈epTools charting in a new country in 5 chartsGermany · United Kingdom · India · Italy · +1 more
- 📈epTools entered the top 100 in 4 chartsTop Paid · Medical · AU · Top Grossing · Medical · AU · Top Paid · Medical · GB · Top Paid · Medical · US
- 🆕epTools first spotted by AppInsider#92 in Top Paid · Medical · Russia
- 📦epTools version 4.0.2bug fixes including crash when performing certain searches
- 🆕epTools released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
epTools on the App Store
App details
epTools downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Active users
All platforms, worldwide. Free with an account.
How this is calculated
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| MedicalPaid | #94 | |
| MedicalPaid | #110 | |
| MedicalPaid | #194 | |
| MedicalPaid | #158 | |
| MedicalPaid | #192 | |
| MedicalPaid | #168 |
Apps near epTools on the chart
Medical Paid, around #94.
Ratings
App Store, worldwide.
Review momentum
ⓘ How we measure thisReview momentum (0-100) blends how fast the app collects ratings compared with other apps in its category (60%), whether that pace is speeding up (25%) and what recent raters give it (15%; recent stars well below lifetime pull it down). Ratings counts are read daily. A jump usually means a launch, a feature, ads or a new review prompt.
What users say about epTools
From the 11 most recent App Store reviews in the US.
Mostly positive (82% of recent reviews give 4–5 stars). People like it for being useful, and being easy to use. Recent reviews are more negative than earlier ones.
What people like
- Useful: “great app, very useful, and easy to use”
- Ease of use: “great app, very useful, and easy to use”
- Updates: “Addendum: remains excellent with update to 2.0”
- Features & content: “This tool is easy to use so much that u can use during a case”
About epTools
Resources include algorithms used to localize arrhythmia substrates and reference guides to assist in the identification and, management of cardiac rhythm disorders and tools to calculate commonly used measurements and risk scores. Peer-reviewed algorithms are implemented by tools via an intuitive user interface. References are provided. Tools guide the user or AI through a series of questions to arrive at an answer while providing a graphical visualization of their progress and result of their analysis.
Use of the save path to image feature allows users to save an image of the current decision path when using many of the decision analysis tools included. These images, which appear in the photo album, may be useful to communicate findings with colleagues.
Included tools:
Preexcitation variant localization:
Arruda, Milstein, Taguchi , D'Avila, Li, Pambrun, Baek and Crinion and O'Leary et al.
Atrial tachycardias:
Ellenbogen and Kistler et al (localization )
De Ponti et al tool (calculates the appropriate mapping window for isthmus identification)
Miyazaki et al (localizes macro reentrant ATs based on pacing responses)
Ischemic ventricular tachycardia localization:
Miller, Segal and Andreu et al)
Idiopathic ventricular tachycardia and premature ventricular contraction:
Ito, Park and Enriquez et al (localization)
ABC-VT Risk Score
Differentiation of left vs right ventricular outflow tract sites:
QRS-RVA Interval
V₂S/V₃R Index
TZ Index
V₂ Transition ratio
R/S-wave Amplitude, R-Wave Duration, R-wave amplitude, V₂QRSI40 and RV₁-₃ indices.
Differentiate endocardial from epicardial VTs:
Maximum deflection index
Daniels and Berruezo et al criteria
Differentiate SVT from VT:
Brugada, Verckei and Moccetti et al
Disease Assessment:
Consensus criteria for ARVD/C and Short QT Syndrome
5-yr risk of SCD in HCM (O'Mahon et al, and AHA)and LQTS (1-2-3-LQTS-Risk)
5-yr risk of life threatening VTA with LMNA variant
Inadequate DFT safety margin (Hsu et al )
LA arrhythmogenic substrate (Kosiuk et al, D'Ambrosio et al)
30-day mortality after PPM and ICD lead extraction (Brunner et al)
1-4 year mortality in 1° prevention ICD placement (Bilchick et al, SHOCKED)
Shanghai score (Brugada Syndrome),
VT prediction in ARVD/C (Cadrin-Tourigny et al.)
Suspicious Index In Lyme Carditis (SILC)
PADIT and BLISTER CIED infection risk
Misc:
Confirm conduction system capture with LBBAP.
myPace personalized heart rate calculator
A CIED/electrocautery manager is included. Detailed preoperative plans can be created and shared by text or email.
Clinical guidelines and consensus statement resource i
CHADS₂, CHA₂DS₂VASc and ATRIA stroke risk, HAS-BLED bleeding risk scores,
QT correction heart rate (Bazett or Fredericia, Hodges) and left bundle branch block (Bogos